# David Matthews

> David Matthews, PhD, is Chief Business Officer at Beacon Biosignals, the computational neurodiagnostics company turning EEG brain data into AI-powered biomarkers for neurological and psychiatric disease. A computational neuroscientist by training, he spent two decades moving between the lab, the boardroom, and the market - from NIH- and NSF-funded research at the Salk Institute to a partnership at Boston Consulting Group to commercial leadership at digital-health platform BrightInsight. He now drives partnerships and commercial growth at a company betting that the brain can be measured at home, at scale.

- **Role:** Chief Business Officer at Beacon Biosignals
- **Organizations:** Beacon Biosignals, BrightInsight, Boston Consulting Group, Salk Institute, University of California San Diego, Princeton University
- **Nationality:** American
- **Education:** BA, Molecular Biology and Bioengineering, Princeton University, PhD, Computational Neurobiology, University of California San Diego / Salk Institute
- **Known for:** Appointed Chief Business Officer of Beacon Biosignals in 2024, Made Partner at Boston Consulting Group across biopharma and medical diagnostics, Drove commercial growth at BrightInsight, a regulated Software as a Medical Device platform

## Career timeline

- **—** — NIH- and NSF-funded neuroscience research at the Salk Institute and UCSD
- **—** — Partner at Boston Consulting Group, leading biopharmaceutical and medical technology practices
- **—** — Chief Growth / Commercial Officer at BrightInsight, driving commercialization over four years of growth
- **2024** — Appointed Chief Business Officer at Beacon Biosignals (February 1, 2024)
- **2026** — Spoke at CES on innovating for women's health and closing market gaps, presented by BCG

## Achievements

- Appointed Chief Business Officer of Beacon Biosignals in 2024
- Made Partner at Boston Consulting Group across biopharma and medical diagnostics
- Drove commercial growth at BrightInsight, a regulated Software as a Medical Device platform
- Recipient of awards and funding from the NIH, NSF, and BCG's Henderson Institute
- Published research spanning machine learning, bioinformatics, brain imaging, sensory processing, and health economics

## Latest updates

- **2026-01** — Spoke at CES on innovating for women's health and closing a $100B market gap, in a session presented by BCG.
- **2025-11** — Beacon Biosignals announced an $86M Series B raise to accelerate AI-driven insights into brain health.

## Links

- Website: https://beacon.bio
- LinkedIn: https://www.linkedin.com/in/dawima/

---

Profile page: https://yespress.io/david-matthews
Published by YesPress — https://yespress.io
Last updated: 2026-06-13